Clinical trial
Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction With Hypertonic Saline in Patient With Moderately Severe or Severe Symptomatic Severe Hyponatremia (SALSA Trial)
NCT02887469 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction With Hypertonic Saline in Patient With Moderately Severe or Severe Symptomatic Severe Hyponatremia (SALSA Trial)
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2016
- Completion date
- September 30, 2019
- Enrollment
- 178 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
hyponatremia symptomatic